NCT01150422

Brief Summary

This trial will compare the efficacy and acceptability of post-medical abortion follow-up by assigning women to either 1) alternative follow-up via routine semi-quantitative pregnancy test and a self-administered follow-up questionnaire, or 2) the standard of care: a routine follow-up visit including a bimanual exam and vaginal ultrasound. The goal of the study is to provide answers to the following questions:

  1. 1.Is a follow-up protocol that employs a self-administered questionnaire and at home use of a semi-quantitative pregnancy test effective at identifying women with ongoing pregnancies?
  2. 2.Is an innovative follow-up protocol more acceptable to women and providers than the current standard of care?
  3. 3.Is an innovative follow-up protocol feasible to implement in abortion services in Vietnam?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Apr 2010

Shorter than P25 for phase_3

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 7, 2010

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 25, 2010

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

May 2, 2011

Status Verified

April 1, 2011

Enrollment Period

1 year

First QC Date

May 7, 2010

Last Update Submit

April 29, 2011

Conditions

Keywords

medical abortion

Outcome Measures

Primary Outcomes (1)

  • Continued, ongoing pregnancy

    9 months

Secondary Outcomes (2)

  • percentage of women who return for follow-up

    9 months

  • percentage of women receiving other treatment for ongoing pregnancy

    9 months

Study Arms (2)

Standard of care for post medical abortion follow-up

NO INTERVENTION

Standard of care includes a routine hospital visit two weeks after mifepristone administration. At the hospital visit, the woman will undergo a bimanual and vaginal ultrasound examination. In the event the woman fails to return for the follow-up visit, each hospital will follow their standard procedure for contacting women who fail to attend their follow-up visit, i.e. three efforts to contact the woman. Form 2a will document the results of any clinical examinations, any additional medical abortion-related care given and the abortion outcome. At the follow-up visit, women will also be asked about the acceptability of current medical abortion follow-up procedures and their future preferences.

Alternative follow-up

ACTIVE COMPARATOR

At their first clinic visit, women will be asked to provide their phone number for contact purposes. Women will also be asked to complete a semi-quantitative pregnancy test in the clinic and the results of the test will be noted on a study form. After mifepristone administration, women will be provided with a second semi-quantitative pregnancy test and a self-administered checklist. Women will be instructed to complete the checklist and perform the pregnancy test at home on an assigned date two weeks after mifepristone administration. The checklist will indicate that if the woman answers "yes" to any of the questions, then she should return to the clinic for a follow-up visit. On the assigned date, women will also be contacted by phone by the clinic staff. Women will be asked to confirm whether they completed the pregnancy test and checklist and asked to report on the results of both tests.

Other: Alternative follow-up

Interventions

After mifepristone administration, women will be provided with a second semi-quantitative pregnancy test and a self-administered checklist. Women will be instructed to complete the checklist and perform the pregnancy test at home on an assigned data two weeks after mifepristone administration. On the assigned date, women will also be contacted by phone by the clinic staff. Women will be asked to confirm whether they completed the pregnancy test and checklist and asked to report on the results of both tests. Provider will review the women's responses to the checklist and confirm whether, based on the woman's responses, she should return for a follow up visit. During the follow-up phone call, women will also be asked about the satisfaction and acceptability of the alternative follow-up procedure.

Alternative follow-up

Eligibility Criteria

Age13 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Reproductive age women seeking medical abortion services
  • Intrauterine pregnancy less than or equal to 63 days gestation on the day of mifepristone administration
  • Hold a working, personal phone number
  • be willing and able to sign consent forms and agree to comply with study procedures

You may not qualify if:

  • Pregnancy greater than 63 days gestation on the day of mifepristone administration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Hanoi Ob-Gyn Hospital

Hanoi, Vietnam

Location

National Ob-Gyn Hospital

Hanoi, Vietnam

Location

HocMon District Hospital

Ho Chi Minh City, Vietnam

Location

Hung Vuong Hospital

Ho Chi Minh City, Vietnam

Location

Related Publications (1)

  • Ngoc NTN, Bracken H, Blum J, Nga NTB, Minh NH, van Nhang N, Lynd K, Winikoff B, Blumenthal PD. Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam: a randomized controlled trial. Obstet Gynecol. 2014 Jan;123(1):88-95. doi: 10.1097/AOG.0000000000000050.

Study Officials

  • Nguyen Thi Nhu Ngoc, MD, MSc

    Center for Research and Consultancy in Reproductive Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 7, 2010

First Posted

June 25, 2010

Study Start

April 1, 2010

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

May 2, 2011

Record last verified: 2011-04

Locations